Skip to main content
Log in

De langetermijngevolgen van mdma-gebruik op het serotonerge systeem, het werkgeheugen en impulsiviteit

  • Artikelen
  • Published:
Neuropraxis

Samenvatting

3,4-methyleendioxymethamfetamine (mdma), ook wel xtc of ecstasy genoemd, is een populaire recreatieve drug (De Win et al., 2005; Jellinek, 2007). Er bestaan vermoedens dat het gebruik op de lange termijn schadelijke gevolgen heeft voor het serotonerge systeem en daarmee op fysiek, emotioneel en cognitief gebied (Gouzoulis-Mayfrank & Daumann, 2006a, McCann et al., 2008; Thomasius et al., 2006). Het mdma-onderzoek kent een aantal complicerende factoren van grotendeels methodologische aard, die zijn besproken in Neuropraxis 4, 2009, 83-88. Dit artikel beperkt zich tot een analyse van de gevolgen op lange termijn, vanaf een aantal maanden, van mdma-gebruik op de serotoninehuishouding en twee cognitieve aspecten: werkgeheugen en impulsiviteit.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatuur

  • Allen, P.P., Cleare, A.J., Lee, F., Fusar-Poli, P., Tunstall, N., Fu, C. H. et al. (2006). Effect of acute tryptophan depletion on pre-frontal engagement. Psychopharmacology (Berlijn), 187,4, 486-497.

  • Ashcraft, M.H. (2002). Cognition (3 ed.). New Jersey: Pearson Education.

  • Back-Madruga, C., Boone, K.B., Chang, L., Grob, C.S., Lee, A., Nations, H. et al. (2003). Neuropsychological effects of 3,4-methylenedioxymethamphetamine (mdma or ecstasy) in recreational users. Clinical Neuropsychology, 17,4, 446-459.

  • Bedi, G. & Redman, J. (2008). Psychological Medicine, 38, 1319–1330.

    Google Scholar 

  • Bogt, T. F. ter & Engels, R.C. (2005). ‘Partying’ hard: party style, motives for and effects of mdma use at rave parties. Substance Use & Misuse, 40,9-10, 1479-1502.

    Google Scholar 

  • Buchert, R., Schulze, O., Wilke, F., Berding, G., Thomasius, R., Petersen, K. et al. (2006). Is correction for age necessary in spect or pet of the central serotonin transporter in young, healthy adults? Journal of Nuclear Medicine, 47,1, 38-42.

    Google Scholar 

  • Buchert, R., Thomasius, R., Nebeling, B., Petersen, K., Obrocki, J., Jenicke, L. et al. (2003). Long-term effects of ‘ecstasy’ use on serotonin transporters of the brain investigated by pet. Journal of Nuclear Medicine, 44,3, 375-384.

    Google Scholar 

  • Buchert, R., Thomasius, R., Wilke, F., Petersen, K., Nebeling, B., Obrocki, J. et al. (2004). A voxel-based pet investigation of the long-term effects of ‘Ecstasy’ consumption on brain serotonin transporters. American Journal of Psychiatry, 161,7, 1181-1189.

    Google Scholar 

  • Chamberlain, S.R., Muller, U., Robbins, T. W. & Sahakian, B. J. (2006). Neuropharmacological modulation of cognition. Current Opinion in Neurology, 19,6, 607-612.

    Google Scholar 

  • Clark, L., Roiser, J.P., Robbins, T.W. & Sahakian, B.J., (2009). Disrupted reflection impulsivity in cannabis users but not current or former ecstasy users. Journal of Psychopharmacology, 23,1, 14-22.

    Google Scholar 

  • Clemens, K.J., McGregor, I.S., Hunt, G.E., & Cornish, J.L. (2007). mdma, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research. Drug and Alcohol Review, 26,1, 9-15.

    Google Scholar 

  • Cowan, R.L. (2007). Neuroimaging research in human mdma users: a review. Psychopharmacology (Berlijn), 189,4, 539-556.

    Google Scholar 

  • Cowan, R.L., Haga, E., de, B.F.B., Dietrich, M.S., Vimal, R.L., Lukas, S.E. et al. (2006). mdma use is associated with increased spatial bold fmri visual cortex activation in human mdma users. Pharmacology Biochemistry and Behavior, 84,2, 219-228.

  • Dafters, R.I. (2006). Impulsivity, inhibition and negative priming in ecstasy users. Addictive Behaviors, 31,8, 1436-1441.

    Google Scholar 

  • Daumann, J., Jr., Fischermann, T., Heekeren, K., Thron, A. & Gouzoulis-Mayfrank, E. (2004). Neural mechanisms of working memory in ecstasy (mdma) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study. Biological Psychiatry, 56,5, 349-355.

  • De Sola Llopis, S., Miguelez-Pan, M., Peña-Casanova, J., Poudevida, S., Farré, M., Pacifici, R., Böhm, P., Abanades, S., Verdejo García, A., Langohr, K., Zuccaro P. & de la Torre, R.(2008). Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study. Journal of Psychopharmacology, 22, 498-510.

  • Devlin, H. (2007). Introduction to fmri. http://www.fmrib.ox.ac.uk/resources/education/fmri/introduction-to-fmri/.

  • Frei, E., Gamma, A., Pascual-Marqui, R., Lehmann, D., Hell, D. & Vollenweider, F. X. (2001). Localization of mdma-induced brain activity in healthy volunteers using low resolution brain electromagnetic tomography (loreta). Human Brain Mapping, 14,3, 152-165.

  • Fox, H.C., McLean, A., Turner, J.J., Parrott, A.C., Rogers, R. & Sahakian, B.J. (2002). Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free mdma (‘ecstasy’) polydrug users. Psychopharmacology (Berlijn), 162,2, 203-214.

  • Gazzaniga, M.S., Ivry, R.B., Mangun, G.R. (2002). Cognitive Neuroscience: The Biology of the Mind (2 ed.). New York: W. W. Norton & Company.

  • Gouzoulis-Mayfrank, E. & Daumann, J. (2006a). Neurotoxicity of methylenedioxyamphetamines (mdma; ecstasy) in humans: how strong is the evidence for persistent brain damage? Addiction, 101,3, 348-361.

  • Gouzoulis-Mayfrank, E. & Daumann, J. (2006b). The confounding problem of polydrug use in recreational ecstasy/mdma users: a brief overview. Journal of Psychopharmacology, 20,2, 188-193.

    Google Scholar 

  • Gouzoulis-Mayfrank, E., Thimm, B., Rezk, M., Hensen, G. & Daumann, J. (2003). Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users. Progress in Neuro-psychopharmacology and Biological Psychiatry, 27,5, 819-827.

    Google Scholar 

  • Green, A.R., Mechan, A.O., Elliott, J.M., O’Shea, E. & Colado, M.I. (2003). The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (mdma, ‘ecstasy’). Pharmacological Reviews, 55,3, 463-508.

  • Han, D.D., & Gu, H.H. (2006). Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. bmc Pharmacology, 6, 6.

  • Hanson, K.L., Luciana, M. & Sullwold, K.(2008). Reward-related decision-making deficits and elevated impulsivity among mdma and other drug users. Drug and Alcohol Dependence, 96,1-2, 99-110.

    Google Scholar 

  • Jacobsen, L.K., & Mencl, W. (2004). Preliminary evidence of hippocampal dysfunction in adolescent mdma (‘ecstasy’) users: possible relationship to neurotoxic effects. Psychopharmacology (Berlijn), 173,3-4, 383-390.

    Google Scholar 

  • Jager, G, Win, M.M.L. de, Tweel, I. van der, Schilt, T., Kahn, R.S., Brink, W. van den, Ree, J.M. van & Ramsey, N.F. (2007). Assessment of cognitive brain function in ecstasy users and contributions of other drugs of abuse: results from an fmri study. Neuropsychopharmacology, 33,2, 247-258.

  • Jellinek (2007). xtc. http://www.jellinek.nl/drugsvoorlichting/matrix-sub.php?m=drugsvoorlichting&r=2&s=5

  • McCann, U. D., Szabo, Z., Seckin, E., Rosenblatt, P., Mathews, W. B., Ravert, H. T., et al. (2005). Quantitative pet studies of the serotonin transporter in mdma users and controls using [11C]McN5652 and [11C]DASB. Neuropsychopharmacology, 30(9), 1741-1750.

    Google Scholar 

  • McCann, U.D., Szabo, Z., Vranesic, M., Palermo, M., Mathews, W.B., Ravert, H.T., Dannals, R.F. & Ricaurte, G.A. (2008). Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent 3, 4-methylenedioxymethamphetamine (‘ecstasy’) users: relationship to cognitive performance. Psychopharmacology, 200,3, 439-450.

  • Moeller, F.G., Steinberg, J.L., Dougherty, D.M., Narayana, P. ., Kramer, L.A., & Renshaw, P.F. (2004). Functional mri study of working memory in mdma users. Psychopharmacology (Berlijn), 177,1-2, 185-194.

  • Montgomery, C., Fisk, J.E., Newcombe, R., Wareing, M. & Murphy, P.N. (2005). Syllogistic Reasoning Performance in mdma (Ecstasy) Users. Experimental and Clinical Pharmacology, 13,2, 137-45

    Google Scholar 

  • Mowla, A., Mosavinasab, M. & Pani, A. (2007). Does fluoxetine have any effect on the cognition of patients with mild cognitive impairment? A double-blind, placebo-controlled, clinical trial. Journal of Clinical Psychopharmacology, 27,1, 67-70.

    Google Scholar 

  • Neath, I.S. & Surprenant, A.M. (2003). Human Memory. Belmont: Wadsworth/Thomson Learning.

  • OShea, E., Escobedo, I., Orio, L., Sanchez, V., Navarro, M., Green, A.R. et al. (2005). Elevation of ambient room temperature has differential effects on mdma-induced 5-ht and dopamine release in striatum and nucleus accumbens of rats. Neuropsychopharmacology, 30,7, 1312-1323.

  • Parrott, A.C., Rodgers, J., Buchanan, T., Ling, J., Heffernan, T. & Scholey, A.B. (2006). Dancing hot on Ecstasy: physical activity and thermal comfort ratings are associated with the memory and other psychobiological problems reported by recreational mdma users. Human Psychopharmacology, 21,5, 285-298.

    Google Scholar 

  • Quednow, B.B., Kuhn, K. ., Hoppe, C., Westheide, J., Maier, W., Daum, I. et al. (2007). Elevated impulsivity and impaired decision-making cognition in heavy users of mdma (‘Ecstasy’). Psychopharmacology (Berlijn), 189,4, 517-530.

  • Raj, V., Liang, H., Woodward, N., Bauernfeind, A., Lee, J., Dietrich, M., Park, S. & Cowan, R. (2009). mdma (ecstasy) use is associated with reduced bold signal change during semantic recognition in abstinent human polydrug users: a preliminary fmri study. Journal of Psychopharmacology, 0, 1-15.

  • Reneman, L., Booij, J., de Bruin, K., Reitsma, J.B., Wolff, F. A. de, Gunning, W. B. et al. (2001a). Effects of dose, sex, and long-term abstention from use on toxic effects of mdma (ecstasy) on brain serotonin neurons. Lancet, 358,9296, 1864-1869.

  • Reneman, L., Win, M.M. de, Brink, W., van den Booij, J. & Heeten, G.J. den (2006). Neuroimaging findings with mdma/ecstasy: technical aspects, conceptual issues and future prospects. Journal of Psychopharmacology, 20,2, 164-175.

  • Roiser, J.P., Rogers, R.D., Cook, L.J. & Sahakian, B.J. (2006). The effect of polymorphism at the serotonin transporter gene on decision-making, memory and executive function in ecstasy users and controls. Psychopharmacology (Berlijn), 188,2, 213-227.

  • Roiser, J.P., Rogers, R.D. & Sahakian, B. . (2007). Neuropsychological function in ecstasy users: a study controlling for polydrug use. Psychopharmacology (Berlijn), 189,4, 505-516.

  • Schilt T., Goudriaan, A.E., Koeter, M.W., Brink, W. van den, & Schmand. B, (2009). Decision making as a predictor of first ecstasy use: a prospective study. Psychopharmacology (Berlijn), 203,3, 519-27.

  • Schilt, T., Win, M.M. de, Jager, G., Korf, D.J., Brink, W. van den et al. (2007). Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study. Archives of General Psychiatry, 64,6, 728-736.

    Google Scholar 

  • Schilt, T., Win, M.M. de, Jager, G., Koeter, M., Ramsey, N.F., Schmand, B., Brink, W. van den, (2008). Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users. Psychological Medicine, 38,09, 1309-1317.

  • Schmitt, J.A., Wingen, M., Ramaekers, J.G., Evers, E.A. & Riedel, W.J. (2006). Serotonin and human cognitive performance. Current Pharmaceutical Design, 12,20, 2473-2486.

    Google Scholar 

  • Soar, K., & Parrott, A. (2004). Persistent neuropsychological problems after 7 years of abstinence from recreational ecstasy (mdma): A case study. Psychological Reports, 95,2, 192-196.

    Google Scholar 

  • Szabo, Z., McCann, U.D., Wilson, A.A., Scheffel, U., Owonikoko, T., Mathews, W. B. et al. (2002). Comparison of (+)-(11)C-McN5652 and (11)c-dasb as serotonin transporter radioligands under various experimental conditions. Journal of Nuclear Medicine, 43,5, 678-692.

    Google Scholar 

  • Terner, J., & Wit, H. de (2006). Menstrual cycle phase and responses to drugs of abuse in humans. Drug and alcohol dependence, 84, 1-13.

    Google Scholar 

  • Thomasius, R., Petersen, K., Buchert, R., Andresen, B., Zapletalova, P., Wartberg, L. et al. (2003). Mood, cognition and serotonin transporter availability in current and former ecstasy (mdma) users. Psychopharmacology (Berlijn), 167,1, 85-96.

    Google Scholar 

  • Thomasius, R., Zapletalova, P., Petersen, K., Buchert, R., Andresen, B., Wartberg, L. et al. (2006). Mood, cognition and serotonin transporter availability in current and former ecstasy (mdma) users: the longitudinal perspective. Journal of Psychopharmacology, 20,2, 211-225.

  • Verdejo-Garcia, A., Lawrence, A.J. & Clark, L. (2008). Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neuroscience and Biobehavioral Reviews, 32, 777-810.

    Google Scholar 

  • Verheyden, S.L., Henry, J.A. & Curran, H. . (2003). Acute, sub-acute and long-term subjective consequences of ecstasy (mdma) consumption in 430 regular users. Human Psychopharmacology, 18,7, 507-517.

  • Wager, T.D., & Smith, E.E. (2003). Neuroimaging studies of working memory: a meta-analysis. Cognitive, Affective and Behavioural Neuroscience, 3,4, 255-274.

    Google Scholar 

  • Wareing, M., Fisk, J.E., Montgomery, C., Murphy, P.N. & Chandler, M.D. (2007). Information processing speed in ecstasy (mdma) users. Human Psychopharmacology, 22,2, 81-88.

    Google Scholar 

  • Wareing, M., Fisk, J.E., Murphy, P. & Montgomery, C. (2004). Verbal working memory deficits in current and previous users of mdma. Human Psychopharmacology, 19,4, 225-234.

    Google Scholar 

  • Wareing, M., Fisk, J.E., Murphy, P., & Montgomery, C. (2005). Visuo-spatial working memory deficits in current and former users of mdma (ecstasy). Human Psychopharmacology, 20,2, 115-123.

  • Win, M.M. de , Jager, G., Vervaeke, H.K., Schilt, T., Reneman, L., Booij, J. et al. (2005). The Netherlands xtc Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance. International Journal of Methods in Psychiatric Research, 14,4, 167-185.

  • Win, M.M. de, Reneman, L., Jager, G., Vlieger, E.J., Olabarriaga, S.D., Lavini, C. et al. (2007). A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users. Neuropsychopharmacology, 32,2, 458-470.

  • Win, M.M. de, Reneman, L., Reitsma, J B., Heeten, G.J. den, Booij, J. & Brink, W. van den (2004). Mood disorders and serotonin transporter density in ecstasy users - the influence of long-term abstention, dose, and gender. Psychopharmacology (Berlijn), 173,3-4, 376-382.

  • Win, M.M. de, Schilt, T., Reneman, L., Vervaeke, H., Jager, G., Dijkink, S., Booij, J. & Brink, W. van den (2006). Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study. Journal of Psychopharmacology, 20,2, 226-35.

  • Zakzanis, K.K., & Young, D.A. (2001). Memory impairment in abstinent mdma (‘Ecstasy’) users: a longitudinal investigation. Neurology, 56,7, 966-969.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Drs. J.A.R. van der Heijden, psycholoog, Bonairestraat 44 II, 1058 XJ Amsterdam.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heijden, J. De langetermijngevolgen van mdma-gebruik op het serotonerge systeem, het werkgeheugen en impulsiviteit. NEPR 13, 124–132 (2009). https://doi.org/10.1007/BF03080165

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03080165

Navigation